Actual benefit of chemo-hormonal therapy in non-castrate metastatic prostate cancer

Future Oncol. 2015;11(8):1141-3. doi: 10.2217/fon.15.36.
No abstract available

Keywords: androgen-deprivation treatment; castration-resistant; chemo-hormonal treatment; docetaxel; hormone sensitive; prostate cancer.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary
  • Clinical Trials, Phase III as Topic
  • Docetaxel
  • Gonadotropin-Releasing Hormone / administration & dosage
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Randomized Controlled Trials as Topic
  • Taxoids / administration & dosage

Substances

  • Taxoids
  • Docetaxel
  • Gonadotropin-Releasing Hormone